Ictus and antiphospholipid syndrome: how much is enough?
Herein we report the case of a patient with antiphospholipid Syndrome (APS) and an ischemic stroke suffered while he was anticoagulated, and we discuss the usefulness of magnetic resonance angiography in the early diagnosis of such a complication. We also attempt to emphasize the great value of an individual risk evaluation when warfarin therapy is introduced. In fact, our case supports the importance of high-intensity anticoagulation in patients with multiple thrombotic recurrences, and the exceptional value that strict anticoagulation control has in this kind of patients.
Rodríguez-Castellano
Elena
E
Servicio de Medicina Interna, Hospital Universitario La Paz, P de la Castellana, 261-28046 Madrid, Spain. elena.rodriguez.c@gmail.com
Ríos-Blanco
Juan José
JJ
Robles-Marhuenda
Angel
A
Gil-Aguado
Antonio
A
Soto-Abánades
Clara
C
Pérez-Valero
Ignacio
I
Royo-Orejas
Arantxa
A
Vázquez-Rodríguez
Juan José
JJ
D017153:Antibodies, Anticardiolipin / Q000097:blood*; D000925:Anticoagulants / Q000008:administration & dosage* / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D018810:Magnetic Resonance Angiography; D008297:Male; D008875:Middle Aged; D020521:Stroke / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage* / Q000627:therapeutic use
D017153:Antibodies, Anticardiolipin; D000925:Anticoagulants; D014859:Warfarin